SITE013-0245

SITE013 (USA) › SITE013-0245

SITE013-0245

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE013 (USA) · Dr. Clarke
consented 2026-06-19

enrolled

AEs

1

Serious

0

Dropout signal

–

Adverse events

1

Grade 3 Anaemia — outcome: RECOVERED/RESOLVED; onset 2023-02-24 (study day 62); relationship: not assessed

severe assessed

Data queries

0

No data queries. Open queries would appear here for this patient.